Tiger Brokers

HK StockDetailed Quotes
Provided by Tiger Fintech (Singapore) Pte. Ltd.

CLOUDBREAK-B

4.970
-0.080-1.58%
Volume:187.50K
Turnover:937.36K
Market Cap:4.17B
PE:-3.06
High:5.050
Open:5.050
Low:4.970
Close:5.050
52wk High:9.740
52wk Low:4.900
Shares:839.00M
HK Float Shares:838.89M
Volume Ratio:0.50
T/O Rate:0.02%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-1.624
ROE:--
ROA:-44.38%
PB:-1.62
PE(LYR):-3.06
PS:53.54

Loading ...

OverviewCompanyNewsFilings

Company Profile

Company Name:
CLOUDBREAK-B
Exchange:
SEHK
Establishment Date:
2015
Employees:
60
Office Location:
8921 Research Drive,Irvine,California,United States
Website:
http://cloudbreakpharma.com
Zip Code:
92618
Phone:
- -
Fax:
- -
Introduction:
Cloudbreak Pharma Inc. is a clinical-stage ophthalmology biotechnology company dedicated to the development of various treatments. The Company is focusing on the in-house discovery, development and commercialization of ophthalmic therapies. The Company has two Core Products, CBT-001 and CBT-009, both of which are being proprietarily developed. Its Core Product, CBT-001, is indicated for the treatment of pterygium (a benign proliferative ocular surface disease), and it has commenced a Phase III multi-regional clinical trial (MRCT) in the United States and China. Its Core Product, CBT-009, is indicated for the treatment of juvenile myopia (myopia in children and adolescents aged 5 to 19) and has completed Phase I/II clinical trials. Its other drug candidates are in a relatively early development stage, including two other clinical-stage drug candidates, which are CBT-006 and CBT-004, and four pre-clinical-stage drug candidates, which are CBT-007, CBT-199, CBT-145, and CBT-011.

Directors

Name
Position
NI Jinsong
Chairman of the Board,Executive Director
Van Son DINH
Executive Director
YANG Rong
Executive Director
LAI Hin Wing Henry
Independent Director,Member of the Remuneration and Assessment Committee,Chairman of the Nomination Committee,Audit Committee Member
LIAO Zhong Min
Independent Director,Member of the Remuneration and Assessment Committee,Member of the Nomination Committee,Audit Committee Chairman
NIE Si Jiang
Independent Director,Chairman of the Remuneration and Assessment Committee,Member of the Nomination Committee,Audit Committee Member
LI Jun Zhi
Director
CAO Xu
Director
XIA Zhi Dong
Director

Shareholders

Name
Position
NI Jinsong
CEO
CHEN Qing Zhu
CFO
FENG Ya Fang
CFO,Corporate Secretary
Elizabeth Sharon CAPAN
Compliance Director,Other Senior Executives
Van Son DINH
Senior Technical Personnel
YANG Rong
Chief Science Officer
Abu P ABRAHAM
Other Senior Executives
FANG Wenkui Ken
Other Senior Executives